|
Services
|
Erectile Dysfunction
Post-Prostatectomy Incontinence
Benign Prostatic Hyperplasia (BPH)
Prostate Cancer
Vasectomy
Low T
Men's Health
Kidney Stones
Urinary Incontinence / Overactive
Bladder
Women's Health
|
|
|
|
Robert J. Cornell, MD
|
Dr. Cornell is a board-certified urologist practicing in downtown Houston, Texas.
He completed his residency training at Baylor College of Medicine in the Scott Department
of Urology and his general surgical training in the Michael E. DeBakey Department
of General Surgery.
|
|
|
|
Prosthetic Urology Specialist |
Dr. Cornell is respected as one of the nation's foremost prosthetic
urologists. He specializes in placing both the three-piece inflatable penile implant
and artificial urinary sphincter (AUS) through a single scrotal incision in a single
surgical procedure.
 |
|
|
|
Prostate Cancer
|
Adenocarcinoma of the prostate is the clinical
term for cancerous tumor of the prostate. Prostate cancer confined to the gland
is usually curable. According to the American Cancer Society (ACS),
|
|
|
|
Vasectomy |
Vasectomy represents the
most definitive form of male contraception. This 10-15 minute procedure is usually
completed in the office under local anesthesia without the need for a scalpel incision.
This "no-scalpel" technique permits access to each vas deferens-the tube
carrying sperm from the epididymis/testis to the urethra-through
|
|
|
|
InterStim® Sacral Neuromudulation
|
Over 30 million people in the United States suffer from urinary incontinence or
overactive bladder (OAB). This condition is far more prevalent in women than men.
In the general population, age 15 to 64 years, 10-30% of women, versus 1.5% of men
are affected. Those with OAB often experience
|
|
|
|
|
|
|
VIEW LARGER MAP
|
|
|
Post-Prostatectomy Urinary Incontinence
Post-Prostatectomy Urinary Incontinence
Post-prostatectomy urinary incontinence (PPI) is the term used to identify the involuntary
leakage of urine following radical prostatectomy to treat prostate cancer.
PPI represents a specific form of stress urinary incontinence where increased
abdominal pressure from a cough, sneeze, or simple physical straining results in
the leakage of urine. Under normal conditions, this increase in abdominal
pressure is managed uneventfully by contraction of the external urinary sphincter,
the muscle surrounding the early part of the male urethra, preventing loss of urinary
control. During PPI, this sphincter mechanism is insufficient in maintaining
closure of the urethra, permitting urinary leakage.
Between 5-10% of patients undergoing radical retropubic prostatectomy for prostate
cancer will suffer clinically significant PPI, manageable only with additional therapy.
As many as 30% of patients undergoing prostate cancer surgery will notice some degree
of urinary incontinence postoperatively. The majority of these patients will,
however, regain urinary control within the first post-operative year and require
no additional therapy. If after 9-12 months the patient is dissatisfied with
his level of urinary control, a discussion of the artificial urinary sphincter (AUS-800)
is appropriate. The AUS-800 represents the most effective cure for PPI.
Over 90% of patients report satisfactory urinary control following implantation
and a similar percentage of patients report that they would both undergo the procedure
again and would recommend implantation to a friend suffering similar difficulties.
The AUS-800 can be implanted in under 1 hour through a single small incision in
the scrotum which heals with a nearly imperceptible scar. There are no externalized
components and to the casual observer, as in a public shower or restroom facility,
it is completely unnoticeable.
Artificial
Urinary Sphincter
The
AUS-800 is a device known as the artificial urinary sphincter. This
device is placed completely inside the patient's body to provide simple, discreet
urinary control. The patient controls urination simply by squeezing a small pump.
The AUS-800 has proven to be effective in treating urinary incontinence and is considered
the gold standard by most urologists. With this device, most patients remain dry
with only minor leaks or dribbles of urine, usually during strenuous exercise or
exertion. As with any medical procedure, the AUS-800 is not 100% effective in all
patients. Some patients may require additional protection.
AdVance Trans-obturator Male Sling for Urinary Incontinence
The AdVance™ Male Sling System
from AMS is an innovative, safe and effective procedure for men suffering from mild
stress urinary incontinence. AdVance is a minimally invasive outpatient surgery
that can restore bladder control the day it is performed.
While moderate to severe cases of incontinence in men have been treated surgically
for years, the majority of incontinent men — those only mildly incontinent — have
had few attractive medical options until now.
Worldwide, 55 million men suffer from incontinence; 5 million
men in the United States. AdVance is a treatment for mild stress urinary incontinence
(SUI), a condition in which urine is leaked during physical activity like lifting,
exercising, sneezing and coughing. Most are prostate cancer survivors, having undergone
surgery for the treatment of their cancer with the often unavoidable outcome of
a damaged urinary sphincter. With the advent of the AdVance male sling system, doctors
are now able to offer a viable spectrum of incontinence solutions.
AdVance gives physicians the opportunity to provide real incontinence solutions
to even more prostate cancer survivors.
With the AdVance procedure, a small "sling" made of synthetic mesh is placed inside
the body through small incisions. The sling supports the urethra, restoring normal
bladder control. Most patients are continent immediately following the procedure
and can resume normal, non-strenuous activities shortly thereafter.
ShareThis
|